Inhalation Sciences Sweden AB-医療機器分野:企業M&A・提携分析

◆英語タイトル:Inhalation Sciences Sweden AB - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011015
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Inhalation Sciences Sweden AB (ISAB) develops and sells innovative laboratory equipment for inhalation research and provides drug development services. The company’s product portfolio includes PreciseInhale and LaminarPace systems. It sells tools and services which accelerates the drug discovery timelines to reduce attrition rates in the clinical phase. ISAB’s PreciseInhale, is an advanced laboratory technology system for inhalation drug development in therapeutic areas of asthma and COPD (chronic obstructive pulmonary disease), migraine, impotence, diabetes and influenza. Its PreciseInhale platform is used for screening and preclinical evaluation of candidate drugs and new drug formulations intended for inhalation. The company offers data for pharmacokinetic studies to labs, pharma and research companies. ISAB is headquartered in Huddinge, Sweden.

Inhalation Sciences Sweden AB – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Inhalation Sciences Sweden AB, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Inhalation Sciences Sweden AB, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Inhalation Sciences Sweden AB, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Inhalation Sciences Sweden AB, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Inhalation Sciences Sweden AB, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Inhalation Sciences Sweden AB, Medical Equipment, Deal Details 10
Venture Financing 10
Inhalation Sciences Raises Funds through Venture Financing 10
Equity Offering 11
Inhalation Sciences Raises USD0.4 million in Private Placement of Shares 11
Acquisition 12
KDev Investments Sells Stake in Inhalation Sciences 12
Inhalation Sciences Sweden AB – Key Competitors 13
Inhalation Sciences Sweden AB – Key Employees 14
Inhalation Sciences Sweden AB – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Product News 16
Aug 30, 2017: Inhalation Sciences Sweden- PreciseInhale achieves positive results in Chiesi tests 16
Other Significant Developments 17
Sep 27, 2017: Inhalation Sciences gets large order from AstraZeneca 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Inhalation Sciences Sweden AB, Medical Equipment, Key Facts 2
Inhalation Sciences Sweden AB, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Inhalation Sciences Sweden AB, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Inhalation Sciences Sweden AB, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Inhalation Sciences Sweden AB, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Inhalation Sciences Sweden AB, Deals By Market, 2011 to YTD 2017 8
Inhalation Sciences Sweden AB, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Inhalation Sciences Raises Funds through Venture Financing 10
Inhalation Sciences Raises USD0.4 million in Private Placement of Shares 11
KDev Investments Sells Stake in Inhalation Sciences 12
Inhalation Sciences Sweden AB, Key Competitors 13
Inhalation Sciences Sweden AB, Key Employees 14

★海外企業調査レポート[Inhalation Sciences Sweden AB-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Weifa ASA (WEIFA)-製薬・医療分野:企業M&A・提携分析
    Summary Weifa ASA (Weifa), formerly Aqualis ASA, is a pharmaceutical company that conducts the research and development, manufacture, distribution and sales of pharmaceutical products, lifestyle products and solutions. The company has over the counter (OTC) pharmaceutical market in Norway offering p …
  • Highmark Inc-製薬・医療分野:企業M&A・提携分析
    Summary Highmark Inc (Highmark), a subsidiary of Highmark Health, is a provider of healthcare insurance solutions. The company underwrites various indemnities and offers healthcare insurance products to individuals, families, groups, companies and federal employees. In addition, the company provides …
  • CITIC Telecom International Holdings Ltd (1883):企業の財務・戦略的SWOT分析
    CITIC Telecom International Holdings Ltd (1883) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • Boule Diagnostics AB (BOUL):企業の財務・戦略的SWOT分析
    Summary Boule Diagnostics AB (Boule) is a medical device company that offers hematology diagnostic solutions. The company provides systems and consumer products for complete blood counts to non-institutional healthcare. It offers products such as blood cell counter and instruments, reagents, calibra …
  • Faron Pharmaceuticals Oy (FARN):医療機器:M&Aディール及び事業提携情報
    Summary Faron Pharmaceuticals Oy (Faron) is a clinical stage biopharmaceutical company that conducts clinical stage drug discovery and development. The company's pipeline products focus on cute organ traumas, vascular damage and cancer immunotherapy. It offers Traumakine, that helps to prevent vascu …
  • Endress+Hauser AG:企業の戦略的SWOT分析
    Endress+Hauser AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Viterra Inc.:企業の戦略・SWOT・財務情報
    Viterra Inc. - Strategy, SWOT and Corporate Finance Report Summary Viterra Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Retrophin Inc (RTRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Retrophin Inc (Retrophin) is a biopharmaceutical company that discovers, develops, acquires and commercializes drugs for the treatment of rare diseases. The company’s products include thiola, chenodal and cholbam. It develops drugs for various catastrophic diseases. Retrophin’s pipeline prod …
  • McDonald’s Australia Limited:企業の戦略的SWOT分析
    McDonald's Australia Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Wentworth Resources Ltd (WRL):石油・ガス:M&Aディール及び事業提携情報
    Summary Wentworth Resources Ltd (Wentworth) is an independent upstream oil and gas company. It conducts the exploration and development of oil and natural gas reserves. The company has producing gas assets in Tanzania, oil and gas exploration activities in both Mozambique and Tanzania. The company o …
  • Accuray Inc (ARAY):製品パイプライン分析
    Summary Accuray Inc (Accuray) carries out the development, manufacture and sale of personalized treatment solutions for radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image guided radiation therapy, and adaptive radiation therapy. The company’s major produc …
  • bioMerieux Inc:医療機器:M&Aディール及び事業提携情報
    Summary bioMerieux Inc (bioMerieux), a subsidiary of Institut Merieux SA is a provider of diagnostic solutions. The company offers its products for clinical solutions which include blood culture, cancer diagnostics, cardiovascular disease, cardiovascular pathology, clinical laboratories, companion d …
  • RWE AG:発電所・企業SWOT分析
    RWE AG - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives) …
  • Kuraray Co., Ltd.:企業の戦略・SWOT・財務情報
    Kuraray Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Kuraray Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Vital Images Inc:企業の戦略的SWOT分析
    Vital Images Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Merck KGaA (MRK):企業の財務・戦略的SWOT分析
    Merck KGaA (MRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • InMed Pharmaceuticals Inc (IN)-製薬・医療分野:企業M&A・提携分析
    Summary InMed Pharmaceuticals Inc (InMed), formerly Cannabis Technologies Inc, is a pre-clinical stage biopharmaceutical company which develops, produces and markets plant cannabinoid based pharmaceutical products to related healthcare markets. The company's pipeline products include INM-750 and INM …
  • juwi AG:企業の戦略的SWOT分析
    juwi AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • AC Immune SA (ACIU):製薬・医療:M&Aディール及び事業提携情報
    Summary AC Immune SA (AC Immune) is a biopharmaceutical company that develops products for treating neurodegenerative diseases. It discovers, designs and develops innovative proprietary medicines to prevent, diagnose and treat neurodegenerative diseases associated with protein misfolding. The compan …
  • Kellogg Co:戦略・SWOT・企業財務分析
    Kellogg Co - Strategy, SWOT and Corporate Finance Report Summary Kellogg Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆